{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:27Z","timestamp":1791239067751,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fungal Genetics and Biology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.fgb.2014.10.003","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T14:32:26Z","timestamp":1413210746000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":210,"special_numbering":"C","title":["Cryptococcosis diagnosis and treatment: What do we know now"],"prefix":"10.1016","volume":"78","author":[{"given":"John R.","family":"Perfect","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihana","family":"Bicanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fgb.2014.10.003_b0005","series-title":"Rapid Advice. Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children","author":"Anonymous","year":"2011"},{"key":"10.1016\/j.fgb.2014.10.003_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fgb.2014.10.003_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.fgb.2014.10.003_b0025","doi-asserted-by":"crossref","first-page":"e01494","DOI":"10.1128\/mBio.01494-14","article-title":"Highly recombinant VGII Cryptococcus gattii population develops clonal outbreak clusters through both sexual macroevolution and asexual microevolution","volume":"5","author":"Billmyre","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0035","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fgb.2014.10.003_b0040","doi-asserted-by":"crossref","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","article-title":"Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant","volume":"7","author":"Bratton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0045","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.01800-12","article-title":"Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis","volume":"57","author":"Bratton","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fgb.2014.10.003_b0050","doi-asserted-by":"crossref","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","article-title":"Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status","volume":"8","author":"Brizendine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0055","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: feasibility and power of quantitative CSF cultures to determine fungicidal activity","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.fgb.2014.10.003_b0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01087-13","article-title":"The Cryptococcus neoformans transcriptome at the site of human meningitis","volume":"5","author":"Chen","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0070","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fgb.2014.10.003_b0075","doi-asserted-by":"crossref","first-page":"e01464","DOI":"10.1128\/mBio.01464-14","article-title":"Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal","volume":"5","author":"Engelthaler","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QCO.0b013e32834ab20a","article-title":"Immune reconstitution syndrome and fungal infections","volume":"24","author":"Gupta","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0090","doi-asserted-by":"crossref","first-page":"e71148","DOI":"10.1371\/journal.pone.0071148","article-title":"Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest","volume":"8","author":"Hagen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CVI.00536-12","article-title":"Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid","volume":"20","author":"Hansen","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.fgb.2014.10.003_b0105","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3201\/eid1910.130441","article-title":"Cryptococcus gattii infections in multiple states outside the US Pacific Northwest","volume":"19","author":"Harris","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0110","series-title":"Cryptococcus: From Human Pathogen to Model Yeast","author":"Heitman","year":"2011"},{"key":"10.1016\/j.fgb.2014.10.003_b0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/1471-2164-12-526","article-title":"Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients","volume":"12","author":"Hu","year":"2011","journal-title":"BMC Genom."},{"key":"10.1016\/j.fgb.2014.10.003_b0120","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis","volume":"26","author":"Jackson","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.fgb.2014.10.003_b0125","doi-asserted-by":"crossref","first-page":"e1004261","DOI":"10.1371\/journal.pgen.1004261","article-title":"Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation","volume":"10","author":"Janbon","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.fgb.2014.10.003_b0140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0145","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.fgb.2014.10.003_b0135","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/infdis\/jit099","article-title":"The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis","volume":"207","author":"Jarvis","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.fgb.2014.10.003_b0155","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1128\/IAI.00551-10","article-title":"Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis","volume":"78","author":"Lee","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.fgb.2014.10.003_b0160","doi-asserted-by":"crossref","first-page":"e8630","DOI":"10.1371\/journal.pone.0008630","article-title":"Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa","volume":"5","author":"Lightowler","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0165","article-title":"Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3days of therapy is equivalent to 14days","volume":"5","author":"Livermore","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0175","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose\u2013response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e32835c21d1","article-title":"Cryptococcal immune reconstitution inflammatory syndrome","volume":"26","author":"Longley","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0185","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"Mayanja-Kizza","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0190","first-page":"585","article-title":"Prevalence and correlates of cryptococcal antigen positivity among AIDS patients \u2013 United States, 1986\u20132012","volume":"63","author":"McKenney","year":"2014","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.fgb.2014.10.003_b0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2a7d100cells\/\u03bcL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.fgb.2014.10.003_b0210","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1128\/IAI.00565-09","article-title":"The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii","volume":"77","author":"Ngamskulrungroj","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.fgb.2014.10.003_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00103-12","article-title":"The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model","volume":"3","author":"Ngamskulrungroj","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"issue":"Suppl. 4","key":"10.1016\/j.fgb.2014.10.003_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2012.761134","article-title":"Fungal diagnosis: how do we do it and can we do better?","volume":"29","author":"Perfect","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.fgb.2014.10.003_b0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0235","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JCM.00737-12","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii","volume":"50","author":"Posteraro","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2014.10.003_b0240","doi-asserted-by":"crossref","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997\u20132009","volume":"8","author":"Pyrgos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jit435","article-title":"Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis","volume":"209","author":"Robertson","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0250","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00573-13","article-title":"Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease","volume":"4","author":"Rohatgi","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0255","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0260","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.fgb.2014.10.003_b0265","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/tmi.12157","article-title":"Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay","volume":"18","author":"Rugemalila","year":"2013","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.fgb.2014.10.003_b0270","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0035-9203(97)90393-X","article-title":"The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis","volume":"91","author":"Seaton","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.fgb.2014.10.003_b0280","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/cid\/ciu191","article-title":"Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults","volume":"58","author":"Siddiqi","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fgb.2014.10.003_b0285","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.fgb.2014.10.003_b0295","doi-asserted-by":"crossref","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","article-title":"Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes","volume":"6","author":"Sionov","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.fgb.2014.10.003_b0290","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","article-title":"Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment","volume":"57","author":"Sionov","year":"2013","journal-title":"Antimicrob. Agent Chemother."},{"key":"10.1016\/j.fgb.2014.10.003_b0300","doi-asserted-by":"crossref","first-page":"e88875","DOI":"10.1371\/journal.pone.0088875","article-title":"Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fgb.2014.10.003_b0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fgb.2014.10.003_b0310","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/JCM.03177-13","article-title":"Multilocus sequence typing of serially collected isolates of Cryptococcus from HIV-infected patients in South Africa","volume":"52","author":"Van Wyk","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.fgb.2014.10.003_b0315","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00196-12","article-title":"Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis","volume":"3","author":"Wiesner","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.fgb.2014.10.003_b0320","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/13693780903437876","article-title":"Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997\u20132007","volume":"48","author":"Zhu","year":"2010","journal-title":"Med. Mycol."}],"container-title":["Fungal Genetics and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087184514001868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087184514001868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:19:21Z","timestamp":1650392361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087184514001868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":64,"alternative-id":["S1087184514001868"],"URL":"https:\/\/doi.org\/10.1016\/j.fgb.2014.10.003","relation":{},"ISSN":["1087-1845"],"issn-type":[{"value":"1087-1845","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptococcosis diagnosis and treatment: What do we know now","name":"articletitle","label":"Article Title"},{"value":"Fungal Genetics and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fgb.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}